Description
Urapidil is an α1-adrenergic receptor antagonist and 5-HT1A receptor agonist. Urapidil exhibits antihypertensive activity, inducing vasodilation and decreasing blood pressure without causing reflex tachycardia.
Urapidil is an α1-adrenergic receptor antagonist and 5-HT1A receptor agonist. Urapidil exhibits antihypertensive activity, inducing vasodilation and decreasing blood pressure without causing reflex tachycardia.
Cas No. | 64887-14-5 |
---|---|
Purity | ≥98% |
Formula | C20H29N5O3 • HCl |
Formula Wt. | 423.93 |
Chemical Name | 2,4(1H,3H)-Pyrimidinedione,6-((3-(4-(2-methoxy- phenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-, monohydrochloride |
IUPAC Name | 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione;hydrochloride |
Synonym | Ebrantil |
Melting Point | 156-158°C |
Solubility | Soluble in water. |
Appearance | White Crystal Powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | U6802 MSDS PDF |
---|---|
Info Sheet | U6802 Info Sheet PDF |
Santiveri X, Ledesma M. Urapidil in anesthesiology: pharmacology and indications. Rev Esp Anestesiol Reanim. 1998 May;45(5):189-97. PMID: 9646668.
van Zwieten PA, Chalmers JP. Different types of centrally acting antihypertensives and their targets in the central nervous system. Cardiovasc Drugs Ther. 1994 Dec;8(6):787-99. PMID: 7742257.